Journal: Biomedicines
Article Title: Repurposing Niclosamide as a Novel Anti-SARS-CoV-2 Drug by Restricting Entry Protein CD147
doi: 10.3390/biomedicines11072019
Figure Lengend Snippet: HuR binds BSG mRNA and regulates its expression. ( a ) CD147 expression in COVID-19 patients’ blood samples. Here, 6 out of 19 early patients, 6 out of 36 middle patients, and 0 out of 22 late patients are severely ill (the rest are considered as mild/moderate). ( b ) Western blotting analysis of HuR and CD147 protein in HuR knock-out clones of MDA-MB-231 cells with or without niclosamide treatment. Tubulin was used as the loading control. NIC, niclosamide. ( b’ ) Quantified relative level of CD147 HG and LG in ( b ). ( c ) Western blotting analysis of HuR and CD147 protein in doxycycline-inducible HuR TET-off system in Hela cells. Dox, doxycycline. ( c’ ) Quantified relative level of CD147 and HuR in ( c ). ( d – f ) RNP-IP analysis of relative enrichment of BSG transcripts in HuR-immunoprecipitation in ( d ) H460, ( e ) NL20, and ( f ) WI-38 cells. ( g ) Western blotting of HuR protein in the pull-down complex by BSG RNA probes in NL20 and WI-38 cells. *** p < 0.001; ** 0.001 < p < 0.01; * 0.01 < p < 0.05. NS, not significant. Two-tailed T -test was applied for statistics.
Article Snippet: Human breast cancer cell line MDA-MB-231, colon carcinoma cell line RKO, lung cancer cell line H460, human embryonal kidney (HEK) 293-FT cells, human fibroblast cell line WI-38, human lung bronchus epithelial cell line NL20, and mouse lung cancer cell line Lewis lung-2 (LL/2) were purchased from American Type Culture Collection (ATCC, Manassas, VA, USA).
Techniques: Expressing, Western Blot, Knock-Out, Clone Assay, Control, Immunoprecipitation, Two Tailed Test